Northwestern Mutual Wealth Management
HRTX icon

Northwestern Mutual Wealth Management’s Heron Therapeutics HRTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-188
Closed -$244 – 4292
2025
Q4 		$244 Buy
+188
New +$232 ﹤0.01% 3789
2024
Q4 		– Sell
-53
Closed -$105 – 3731
2024
Q3 		$105 Buy
+53
New +$127 ﹤0.01% 3485
2023
Q3 		– Sell
-1,000
Closed -$1.16K – 3403
2023
Q2 		$1.16K Hold
1,000
– – ﹤0.01% 3067
2023
Q1 		$1.51K Hold
1,000
– – ﹤0.01% 2970
2022
Q4 		$2.5K Hold
1,000
– – ﹤0.01% 2911
2022
Q3 		$4K Hold
1,000
– – ﹤0.01% 2739
2022
Q2 		$3K Sell
1,000
-8
-0.8% -$32 ﹤0.01% 2839
2022
Q1 		$6K Buy
1,008
+8
+0.8% +$59 ﹤0.01% 2680
2021
Q4 		$9K Sell
1,000
-2,600
-72% -$26.5K ﹤0.01% 2597
2021
Q3 		$38K Buy
3,600
+2,600
+260% +$31.7K ﹤0.01% 1993
2021
Q2 		$16K Hold
1,000
– – ﹤0.01% 2283
2021
Q1 		$16K Hold
1,000
– – ﹤0.01% 2144
2020
Q4 		$21K Hold
1,000
– – ﹤0.01% 1940
2020
Q3 		$15K Buy
+1,000
New +$15.6K ﹤0.01% 1884
2020
Q1 		– Sell
-3
Closed – – 2648
2019
Q4 		$0 Buy
+3
New +$66 ﹤0.01% 2487
2019
Q3 		– Sell
-60
Closed -$1K – 2563
2019
Q2 		$1K Buy
60
+22
+58% +$439 ﹤0.01% 2406
2019
Q1 		$1K Sell
38
-262
-87% -$6.86K ﹤0.01% 2419
2018
Q4 		$8K Hold
300
– – ﹤0.01% 1900
2018
Q3 		$9K Hold
300
– – ﹤0.01% 1952
2018
Q2 		$12K Buy
+300
New +$9.55K ﹤0.01% 1776
2017
Q3 		– Sell
-135
Closed -$2K – 2200
2017
Q2 		$2K Buy
+135
New +$1.96K ﹤0.01% 1877

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Northwestern Mutual Wealth Management's HRTX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Heron Therapeutics (HRTX) in Q1 2026, closing a stake of 188 shares — an estimated $244 sold.

Northwestern Mutual Wealth Management first reported a position in HRTX in Q2 2017 and held it in 21 quarters. The position peaked at $38K in Q3 2021. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining Heron Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 188 Heron Therapeutics shares in Q1 2026, an estimated $244.
  • Northwestern Mutual Wealth Management first reported a position in Heron Therapeutics in Q2 2017 and held it in 21 quarters.
  • Northwestern Mutual Wealth Management's Heron Therapeutics position peaked at $38K in Q3 2021.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.